Request Rejected
The requested URL was rejected. Please consult with your administrator.Your support ID is: 16956775938308637134
Related Articles
Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research
As I announced earlier this week, today is my last day as NIH Director. It has truly been my honor to lead this agency and…
Statement on the departure of National Cancer Institute Director Dr.
Dr. Rathmell served as the 17th Director of NCI.
Paving the Way to More Precise Tissue Engineering with the Help of Liquid Metal
The ability to engineer complex biological tissues—such as the tiny air sacs inside our lungs or complex, branching blood vessels throughout our bodies—has vast potential…
Could Engineered Immune Cells Be Used to Treat People with Autoimmune Diseases and Organ Transplants while Reducing Infection Risks?
Millions of people in the U.S. have an autoimmune disease, from type 1 diabetes to inflammatory bowel disease, in which the immune system attacks the…
What is metformin’s secret sauce?
The diabetes drug can target cells contributing to disease progression without harming normal, healthy cells, according to research
Association between fine particulate matter and eczema: A cross-sectional study of the All of Us Research Program and the Center for Air, Climate, and Energy Solutions
Background The prevalence of eczema has increased with industrialization. Industrial practices generate ambient air pollution, including fine particulate matter of diameter ≤ 2.5μm (PM2.5). Studies…
2024 Science Highlights from the NIH Director’s Blog
This year on the NIH Director’s Blog, we covered a wide range of NIH-supported research from across our institutes and centers. We explored exciting new…
Personalized blood count could lead to early intervention for common diseases
A complete blood count (CBC) screening is a routine exam requested by most physicians for healthy adults.Currently, the results of CBC tests are analyzed using…
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Clinical trials are essential for advancing new treatments that improve patient care and lives. But far too many clinical trials face challenges in identifying and…
NIH issues new policy to speed access to agency-funded research
The 12-month embargo period before manuscripts resulting from NIH funding must be made publicly available is removed.